Earnings Quality

The Forensic Verdict

Zydus Wellness earns an Elevated forensic grade — score 45 of 100.AI The core consumer franchise reports cleanly: twelve years of unmodified audit opinions, no CARO qualifications, no Section 143(12) fraud, no promoter pledging, and 5-year CFO/Net-Income of 0.92×.Fact The risk sits squarely in the FY26 M&A overlay.News Adjusted EPS of ₹11.17 sits 80% above GAAP EPS of ₹6.20 after adding back ₹117 Cr of "acquired-brand amortisation" and ₹41 Cr of exceptional items, letting management frame a 43% GAAP PAT collapse as a 2.3% adjusted gain.Fact Naturell India Private Limited — acquired Dec 2024 for ₹390 Cr — was put into voluntary liquidation in July 2025, seven months later.Fact Borrowings at the half-year jumped 16× from ₹188 Cr to ₹3,042 Cr to fund the Comfort Click UK acquisition.News The single data point that would most change the grade is the FY26 Integrated Annual Report (expected around the 2026-08-04 AGM): full Comfort Click PPA, a clean Naturell exit narrative, and audited Note 35 reconciling the ₹41 Cr exceptional bucket would compress the grade toward Watch.AI

Shenanigan Scorecard

One red, six yellow, six green.AI The single red and four of the six yellows cluster around FY26 M&A reporting (Comfort Click + Naturell).News The underlying business — sugar substitutes, oral skincare, glucose powder, butter spreads — passes every revenue-quality and cash-flow test for the twelve years preceding the M&A overlay.Fact

Breeding Ground

Promoter dominance is the structural amplifier.Fact Zydus Lifesciences (formerly Cadila Healthcare) holds 69.64% with zero pledge, and the Patel family controls the parent via Zydus Family Trust.Fact The Chairman (Dr. Sharvil P. Patel) is also Managing Director of the parent; the Non-Executive Director (Mr. Ganesh Nayak) is a parent-company director with 49 years at Zydus.Fact Independent Director Akhil Monappa sits on both the parent's board and on the boards of Alidac UK Limited and Comfort Click Limited — the acquired UK entities that drove the FY26 borrowing jump.Fact Audit-committee independence on paper (4 IDs out of 7 board seats) but the M&A counterparties run through directors with parent-side roles.AI

The picture is mixed.AI Concentration and director overlap raise the prior on aggressive accounting choices clearing internal-review hurdles too easily.AI But every external check — CARO, fraud reporting, IFC opinion, pledge data, audit-trail compliance — comes back clean.Fact The breeding ground tilts the analysis toward giving M&A reporting choices a careful read, not toward assuming the underlying numbers are unreliable.AI

Earnings Quality

The core income statement reads honestly through FY25.Fact The yellow flags begin with the FY26 M&A overlay.News

Revenue versus receivables

DSO has crept from 2 days in FY14 to 49 days in FY25 — a 24× expansion over twelve years.Fact Most of the post-Heinz normalisation (FY19–FY21) is explainable by the integrated business mix (Glucon-D MT/GT distribution differs from pre-merger Sugar Free), but the FY22→FY25 march from 26d → 49d (+88%) outran revenue growth of +35%.AI Inventory days held flat at ~148 days.Fact Of the FY25 ₹367 Cr receivables book, 98% sits under 180 days and the expected credit loss allowance was unchanged at ₹2.3 Cr — qualitatively clean, but the trajectory is the kind of slow-burn working-capital absorption forensic readers track quarter by quarter.Fact

Net income versus operating cash flow

CFO tracked or exceeded NI in 8 of 12 years.AI The standout breach was FY23, when CFO/NI fell to 0.30× as ₹310 Cr of reported profit was absorbed by a ₹145 Cr working-capital build (the same year Sitarganj closure and Rabale disposal absorbed cash).Fact 5-year CFO/NI sits at 0.92×, and FY25 closed cleanly at 1.10×.AI The audited consolidated cash-flow statement reconciles transparently — depreciation ₹284 Cr, ECL ₹0.3 Cr, exceptional non-cash items individually small.Fact

FY26 non-GAAP gap

This is the single red flag.AI The audited GAAP PAT for FY26 is ₹197 Cr — a 43.2% YoY collapse from FY25's ₹347 Cr.Fact The press release leads with "Adjusted Net Profit ₹355 Cr / +2.3% YoY" by adding back ₹117 Cr of amortisation on Comfort Click + Naturell brand intangibles and ₹41 Cr of mixed exceptionals.Fact Two problems.AI First, the amortisation reflects real cash the company spent: ₹369 Cr net for Naturell, plus the (undisclosed at standalone-AR level) Comfort Click consideration.News Adding it back treats the brand-acquisition cost as a sunk option, not a recurring expense, while the brand assets do depreciate economically as products age.AI Second, the ₹41 Cr exceptional bucket bundles three different things — a regulatory change (new labour code), one-time deal costs, and the Naturell liquidation — without per-line disclosure in the press release.Fact The audited FY26 Integrated Annual Report (due around the 2026-08-04 AGM) is the natural resolution point.AI

Cash Flow Quality

Operating cash flow has been honest at the line-item level — but the magnitude is now driven by acquisition geometry as much as by the underlying business.AI

Working capital contribution to CFO

The CCC reversed by 157 days over the past decade — from −82 days in FY14 (vendor-funded business) to +75 days in FY25 (working-capital-funded).AI The collapse is concentrated in days-payable: 662 days in FY19 (the year the Heinz acquisition gave the company a one-time spike in payables) → 122 days in FY25 (an 81% compression).Fact This is not a sudden lifeline — it is a steady drain — but it does mean that any CFO strength the company reports in coming quarters needs to be tested against payable-days drift, not just headline EBITDA.AI

FY26 EBITDA-to-cash conversion

Management discloses FY26 cash conversion at 44% — down from 100% in FY25.Fact The drop is mechanical: Comfort Click's pre-acquisition working-capital base is being absorbed onto the consolidated balance sheet, and ₹98 Cr of new interest expense on the bridge financing flows through CFO before the EUR-loan conversion stabilises.AI But the headline EBITDA of ₹510 Cr (+34%) is the number management points to — the cash that turns into shareholder return is ₹226 Cr, less than half.Fact Forensic readers should anchor on the conversion ratio, not the EBITDA print.AI

Acquisitions and disposals

FCF-after-acquisitions has been deeply negative for the past two years: FY25 ₹315 Cr FCF minus ₹369 Cr Naturell outflow = −₹54 Cr; FY26 ₹226 Cr CFO minus ₹3,042 Cr in net Comfort Click borrowings ≈ structurally negative even before maintenance capex.AI The five-year base case of ~₹220–270 Cr standalone FCF was already known.Fact What the M&A overlay does is shift this consumer franchise from a pure capital-return story to a deleveraging story for the next 3–4 years.AI That is a capital-allocation observation rather than an accounting red flag, but it reinforces why the "Adjusted PAT" framing matters: ₹355 Cr of adjusted PAT does not pay down ₹3,042 Cr of debt at the same rate that the GAAP cash-flow statement says.AI

Metric Hygiene

The metrics ZWL highlights in its FY26 deck deserve the closest read of the entire forensic file.AI

The metric hygiene table is the single most useful artefact in this file.AI The 46-percentage-point gap between Adjusted PAT growth (+2.3%) and GAAP PAT growth (−43.2%) is the largest such gap in the company's twelve-year disclosure history and was introduced in the same quarter (Q4 FY26) that closed the Comfort Click acquisition.AI The amortisation add-back is mechanically standard — but the company is leading the press release with the adjusted number rather than reconciling it as a footnote.Fact Whether this is a one-quarter framing choice or a new permanent reporting style is the cleanest binary test for the next two prints.AI

What to Underwrite Next

The forensic risk does not rise to "thesis-breaking."AI The accounting policies are conservative, the audit opinions are clean, and the underlying consumer franchise generates cash.Fact But the M&A overlay introduces enough yellow that this stock should clear a slightly higher bar on margin-of-safety than its 81× headline P/E currently implies.AI Five things to watch:

1. FY26 Integrated Annual Report (around 2026-08-04 AGM). The provisional Naturell PPA (recognised at standalone-AR level in May 2025) will be finalised.Fact Comfort Click PPA will appear for the first time in audited form.AI CARO Annexure xi(a) on fraud + emphasis-of-matter paragraphs are the cleanest signals.Fact A clean AR with full reconciliation collapses one red and three yellows into greens; any restatement of the Naturell goodwill (₹91 Cr) would push the grade into High.AI

2. Q1 FY27 print (~28 July 2026). Watch for two things — (a) is "Adjusted PAT / Adjusted EPS" still the lead metric in the press release, or has it moved to a footnote, and (b) what is EBITDA-to-CFO conversion when the seasonal Q1 strength (Glucon-D, Nycil) lands on the new debt base.AI A conversion ratio under 60% in Q1 (seasonally the strongest quarter) would be the next yellow.AI

3. Receivables and payables roll-forward. If FY27 DSO exceeds 50 days or DPO falls below 100 days, the slow working-capital drain becomes thesis-relevant.AI Look for these in the FY26 standalone balance sheet (annexed to the AR) and in Q1 FY27 limited-review numbers.Fact

4. Disclosure of Comfort Click borrowing covenants. The FY25 AR explicitly states "As at March 31 2025 and March 31 2024, there are no covenants applicable to the Group."Fact The FY26 ₹3,042 Cr GBP→EUR bridge facility almost certainly carries covenants — undisclosed covenants reduce flexibility around any Naturell-style strategic write-down.AI

5. Tone on Naturell. The Q4 FY26 deck describes Naturell liquidation as "on a going-concern basis" with the business absorbed into ZWPL — the cleanest read of an unusual structure.Fact If management changes the tone (e.g., references "strategic review" of RiteBite Max Protein margins, or any goodwill-impairment language on the ₹91 Cr Naturell-allocated goodwill), the grade moves to High.AI

The forensic verdict in one sentence: the accounting risk is a valuation haircut, not a thesis breaker — apply a 10–15% margin-of-safety discount to the bull-case multiple until the FY26 audited AR closes the open reconciliation items.AI Position sizing should respect that the 81× headline P/E rests on Adjusted PAT framing; the same multiple on GAAP EPS would be 81× × (6.20 / 11.17) ≈ 45× on adjusted earnings, still demanding but no longer extreme.AI The forensic file does not change the long-term franchise quality of Sugar Free, Glucon-D, Nutralite, and Everyuth — it simply says: read the FY26 AR before you size up.Fact